{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:39:31Z","timestamp":1761824371756},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:sec id=\"ab-ooi220031-4\"><jats:title>Importance<\/jats:title><jats:p>Cardiovascular events are an important cause of morbidity in patients with oropharyngeal squamous cell carcinoma (OPSCC). Radiation and chemotherapy have been associated with increased risk of stroke; up-front surgery allows the opportunity for (chemo)radiotherapy de-escalation.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi220031-5\"><jats:title>Objective<\/jats:title><jats:p>To evaluate whether up-front surgery was associated with decreased stroke risk compared to nonsurgical treatment for OPSCC.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi220031-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study was conducted at the US Veterans Health Administration and examined US veterans diagnosed with nonmetastatic OPSCC from 2000 to 2020. Data cutoff was September 17, 2021, and data analysis was performed from October 2021 to February 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi220031-7\"><jats:title>Exposures<\/jats:title><jats:p>Up-front surgical treatment or definitive (chemo)radiotherapy as captured in cancer registry.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi220031-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Cumulative incidence of stroke, accounting for death as a competing risk; and association between up-front surgery and stroke risk. After generating propensity scores for the probability of receiving surgical treatment and using inverse probability weighting (IPW) to construct balanced pseudo-populations, Cox regression was used to estimate a cause-specific hazard ratio (csHR) of stroke associated with surgical vs nonsurgical treatment.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi220031-9\"><jats:title>Results<\/jats:title><jats:p>Of 10\u202f436 patients, median (IQR) age was 61 (56-67) years; 10\u202f329 (99%) were male; 1319 (13%) were Black, and 7823 (75%) were White; 2717 received up-front surgery, and 7719 received nonsurgical therapy with definitive (chemo)radiotherapy. The 10-year cumulative incidence of stroke was 12.5% (95% CI, 11.8%-13.3%) and death was 57.3% (95% CI, 56.2%-58.4%). Surgical patients who also received (chemo)radiotherapy had shorter radiation and chemotherapy courses than nonsurgical patients. After propensity score and IPW, the csHR of stroke for surgical treatment was 0.77 (95% CI, 0.66-0.91). This association was consistent across subgroups defined by age and baseline cardiovascular risk factors.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi220031-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cohort study, up-front surgical treatment was associated with a 23% reduced risk of stroke compared with definitive (chemo)radiotherapy. These findings present an important additional risk-benefit consideration to factor into treatment decisions and patient counseling and should motivate future studies to examine cardiovascular events in this high-risk population.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoto.2022.1327","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T15:35:02Z","timestamp":1655998502000},"page":"740","source":"Crossref","is-referenced-by-count":16,"title":["Association Between Up-front Surgery and Risk of Stroke in US Veterans With Oropharyngeal Carcinoma"],"prefix":"10.1001","volume":"148","author":[{"given":"Lova","family":"Sun","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"},{"name":"Corporal Michael Crescenz VA Medical Center, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Brody","sequence":"additional","affiliation":[{"name":"Corporal Michael Crescenz VA Medical Center, Philadelphia"},{"name":"Division of Otorhinolaryngology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Candelieri","sequence":"additional","affiliation":[{"name":"VA Salt Lake City Health Care System, University of Utah, Salt Lake City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tori","family":"Anglin-Foote","sequence":"additional","affiliation":[{"name":"VA Salt Lake City Health Care System, University of Utah, Salt Lake City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Lynch","sequence":"additional","affiliation":[{"name":"VA Salt Lake City Health Care System, University of Utah, Salt Lake City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara N.","family":"Maxwell","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"},{"name":"Corporal Michael Crescenz VA Medical Center, Philadelphia"},{"name":"Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Damrauer","sequence":"additional","affiliation":[{"name":"Corporal Michael Crescenz VA Medical Center, Philadelphia"},{"name":"Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"},{"name":"Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Ojerholm","sequence":"additional","affiliation":[{"name":"Corporal Michael Crescenz VA Medical Center, Philadelphia"},{"name":"Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John N.","family":"Lukens","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger B.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly D.","family":"Getz","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Ky","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"9","key":"ooi220031r1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002).","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"ooi220031r2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ijrobp.2019.11.021","article-title":"A phase 2 trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): omission of the resected primary tumor bed after transoral robotic surgery for human papilloma virus-related squamous cell carcinoma of the oropharynx.","volume":"106","author":"Swisher-McClure","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10166","key":"ooi220031r3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"ooi220031r4","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/cncr.28588","article-title":"Causes of death in long-term survivors of head and neck cancer.","volume":"120","author":"Baxi","year":"2014","journal-title":"Cancer"},{"issue":"7","key":"ooi220031r5","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998.","volume":"109","author":"Fuller","year":"2007","journal-title":"Cancer"},{"issue":"26","key":"ooi220031r6","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1200\/JCO.2011.35.7301","article-title":"Population-based study of competing mortality in head and neck cancer.","volume":"29","author":"Rose","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"ooi220031r7","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-03-1077","article-title":"Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.","volume":"10","author":"Argiris","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"ooi220031r8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/hed.v36.2","article-title":"Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy.","volume":"36","author":"Dorth","year":"2014","journal-title":"Head Neck"},{"issue":"1","key":"ooi220031r9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.radonc.2013.08.009","article-title":"Radiation-induced carotid artery atherosclerosis.","volume":"110","author":"Gujral","year":"2014","journal-title":"Radiother Oncol"},{"issue":"9","key":"ooi220031r10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/bjc.2011.361","article-title":"Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study.","volume":"105","author":"Chu","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"ooi220031r11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1200\/JCO.2002.20.1.282","article-title":"Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years.","volume":"20","author":"Dorresteijn","year":"2002","journal-title":"J Clin Oncol"},{"issue":"31","key":"ooi220031r12","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1200\/JCO.2008.16.6546","article-title":"Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.","volume":"26","author":"Smith","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"ooi220031r13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijrobp.2013.06.009","article-title":"Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early-stage glottic cancer.","volume":"87","author":"Hong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"ooi220031r14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijcard.2014.04.238","article-title":"Cardiotoxicity: cisplatin and long-term cancer survivors.","volume":"175","author":"Patan\u00e8","year":"2014","journal-title":"Int J Cardiol"},{"issue":"3","key":"ooi220031r15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/hed.v39.3","article-title":"Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy.","volume":"39","author":"Okoye","year":"2017","journal-title":"Head Neck"},{"issue":"4","key":"ooi220031r16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"ooi220031r17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer.","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"30","key":"ooi220031r18","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1200\/JCO.2014.56.5754","article-title":"New chapter in our understanding of human papillomavirus-related head and neck cancer.","volume":"32","author":"Pfister","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"ooi220031r19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311).","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"issue":"22","key":"ooi220031r20","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.19.00463","article-title":"Phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human papillomavirus-associated oropharynx squamous cell carcinoma.","volume":"37","author":"Ma","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"ooi220031r21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amepre.2015.06.011","article-title":"Cardiovascular disease risk factors among male veterans, U.S., 2009-2012.","volume":"50","author":"Fryar","year":"2016","journal-title":"Am J Prev Med"},{"issue":"6","key":"ooi220031r22","first-page":"703","article-title":"Veterans and risk of heart disease in the United States: a cohort with 20 years of follow up.","volume":"5","author":"Assari","year":"2014","journal-title":"Int J Prev Med"},{"issue":"4","key":"ooi220031r23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L","article-title":"Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans.","volume":"72","author":"Mashberg","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"ooi220031r24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2014.09.014","article-title":"Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke.","volume":"169","author":"Navar-Boggan","year":"2015","journal-title":"Am Heart J"},{"issue":"2","key":"ooi220031r25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/EDE.0b013e3182821e75","article-title":"Validation of VA administrative data algorithms for identifying cardiovascular disease hospitalization.","volume":"24","author":"Niesner","year":"2013","journal-title":"Epidemiology"},{"issue":"26","key":"ooi220031r26","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible\u2014the Neighborhood Atlas.","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"ooi220031r28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/QAD.0b013e32832bd7af","article-title":"HIV infection and the risk of diabetes mellitus.","volume":"23","author":"Butt","year":"2009","journal-title":"AIDS"},{"issue":"2","key":"ooi220031r29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/QAI.0000000000000419","article-title":"HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction.","volume":"68","author":"Paisible","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ooi220031r30","doi-asserted-by":"crossref","first-page":"e210070","DOI":"10.1001\/jamanetworkopen.2021.0070","article-title":"Assessment and management of cardiovascular risk factors among US veterans with prostate cancer.","volume":"4","author":"Sun","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"ooi220031r31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"6","key":"ooi220031r32","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/cncr.32654","article-title":"National treatment trends in human papillomavirus-positive oropharyngeal squamous cell carcinoma.","volume":"126","author":"Zhan","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"ooi220031r33","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.amjsurg.2004.01.014","article-title":"Focused high-risk population screening for carotid arterial stenosis after radiation therapy for head and neck cancer.","volume":"187","author":"Steele","year":"2004","journal-title":"Am J Surg"},{"issue":"9","key":"ooi220031r34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jamaoto.2015.1447","article-title":"Characteristics of human papillomavirus-associated head and neck cancers in a veteran population.","volume":"141","author":"Shay","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"8","key":"ooi220031r35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.21.01961","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial.","volume":"40","author":"Nichols","year":"2022","journal-title":"J Clin Oncol"},{"key":"ooi220031r27","unstructured":"University of Wisconsin School of Medicine and Public Health. 2015 Area Deprivation Index v2.0. Accessed October 25, 2019. https:\/\/www.neighborhoodatlas.medicine.wisc.edu\/"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2793421\/jamaotolaryngology_sun_2022_oi_220031_1673476387.80756.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T16:40:17Z","timestamp":1673541617000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2793421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2022.1327","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}